BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Brant L. Kedrowski, William F. Wacholtz. NMR Spectroscopy in the Undergraduate Curriculum: Upper-Level Courses and Across the Curriculum Volume 3ACS Symposium Series 2016; 1225: 17 doi: 10.1021/bk-2016-1225.ch002
2
Sherry C. Wen, John V. Williams, C. J. Papasian. New Approaches for Immunization and Therapy against Human MetapneumovirusClinical and Vaccine Immunology 2015; 22(8): 858 doi: 10.1128/CVI.00230-15
3
Soraya Abad, Almudena Vega, Diego Rincón, Eduardo Hernández, Evangelina Mérida, Nicolás Macías, Raquel Muñoz, Mónica Milla, Jose Luño, Juan Manuel López-Gómez. Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patientsNefrología (English Edition) 2017; 37(2): 158 doi: 10.1016/j.nefroe.2017.04.010
4
Az Alddien Natfji, Helen M.I. Osborn, Francesca Greco. Feasibility of polymer-drug conjugates for non-cancer applicationsCurrent Opinion in Colloid & Interface Science 2017; 31: 51 doi: 10.1016/j.cocis.2017.07.004
5
Chun-Jen Liu. Simple predictor for anemia in chronic hepatitis C patients receiving peginterferon plus ribavirinAdvances in Digestive Medicine 2016; 3(1): 1 doi: 10.1016/j.aidm.2016.01.001
6
Javier Ampuero, Manuel Romero-Gómez. Pharmacogenetics of ribavirin-induced anemia in hepatitis CPharmacogenomics 2016; 17(14): 1587 doi: 10.2217/pgs.16.28
7
Fernanda Bellini Lunardi MICHELS, Ana Cristina de Castro AMARAL, Roberto José de CARVALHO-FILHO, Gustavo de Almeida VIEIRA, Ana Lucia da Silva SOUZA, Maria Lucia Gomes FERRAZ. HEPATITIS C TREATMENT OF RENAL TRANSPLANT AND CHRONIC KIDNEY DISEASE PATIENTS: EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRAL REGIMENS CONTAINING SOFOSBUVIRArquivos de Gastroenterologia 2020; 57(1): 45 doi: 10.1590/s0004-2803.202000000-09
8
Soraya Abad, Almudena Vega, Diego Rincón, Eduardo Hernández, Evangelina Mérida, Nicolás Macías, Raquel Muñoz, Mónica Milla, Jose Luño, Juan Manuel López-Gómez. Eficacia de los antivirales de acción directa en la infección por el virus de la hepatitis C en pacientes en hemodiálisisNefrología 2017; 37(2): 158 doi: 10.1016/j.nefro.2016.10.003
9
Saleh A. Alqahtani, Mark S. Sulkowski. HCV: The Journey from Discovery to a CureTopics in Medicinal Chemistry 2019; 31: 97 doi: 10.1007/7355_2018_59
10
Chao-Ming Shih, Chih-Hsien Wu, Wen-Jun Wu, Yi-Min Hsiao, Jiunn-Liang Ko. Hypericin inhibits hepatitis C virus replication via deacetylation and down-regulation of heme oxygenase-1Phytomedicine 2018; 46: 193 doi: 10.1016/j.phymed.2017.08.009
11
Yasmin Abo-zeid, Gareth R. Williams, Lila Touabi, Gary R. McLean. An investigation of rhinovirus infection on cellular uptake of poly (glycerol-adipate) nanoparticlesInternational Journal of Pharmaceutics 2020; 589: 119826 doi: 10.1016/j.ijpharm.2020.119826
12
Yuan-yuan Ma, Mu-qing Yang, Zhi-gang He, Qing Wei, Ji-yu Li. Biology of Myelomonocytic Cells2017;  doi: 10.5772/67673
13
Ramakrishna Behara, Nancy Reau. Updates on hepatitis C virus therapy in the direct-acting antiviral eraCurrent Opinion in Gastroenterology 2017; 33(3): 115 doi: 10.1097/MOG.0000000000000350